Category: Investor updates

Imagion Biosystems Limited announced a proposed issue of securities on 22 November 2020. Please click to review the full announcement at ASX.  

Imagion Biosystems is pleased to announce it has raised $6M via a placement, at 8.5c per share. The placement, led by Evolution Capital Advisors, was

The securities of Imagion Biosystems Limited (‘IBX’) will be placed in trading halt at the request of IBX, pending it releasing an announcement. Unless ASX

Imagion Biosystems advises that in accordance with Listing Rule 4.7C.3, and as noted in the Item 6 of the Appendix 4C Cashflow Statement lodged by

Imagion Biosystems gave ASX information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Imagion Biosystems has submitted “Appendix 2A — Application for quotation of +securities.” Read Appendix 2A.

Imagion Biosystems has advised that 2,500,000 performance rights have vested and were issued as ordinary shares to Executive Chairman and CEO Bob Proulx today, Thursday

Imagion Biosystems gives notice that, on 20 October 2020 the Company issued 2,401,900 fully paid ordinary shares (Shares) in the Company as the result of

Imagion Biosystems announced that it has received a total of $143,157 for the exercise of options. Composed of $142,200 for 2,370,000 options exercisable at 6